431
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Prognosis of patients with ascites after PleurX insertion: an observational study

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 340-344 | Received 20 Nov 2017, Accepted 29 Jan 2018, Published online: 07 Feb 2018

References

  • Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838–851.
  • Liver EAftSot. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.
  • Annamalai A, Wisdom L, Herada M, et al. Management of refractory ascites in cirrhosis: are we out of date?. World J Hepatol. 2016;8:1182–1193.
  • Pedersen JS, Bendtsen F, Moller S. Management of cirrhotic ascites. Ther Adv Chronic Dis. 2015;6:124–137.
  • Lungren MP, Kim CY, Stewart JK, et al. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol. 2013;24: 1303–1308.
  • Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol. 1993;88:514–519.
  • Younossi ZM, Boparai N, Price LL, et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–2205.
  • Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–178.
  • Campbell MS, Brensinger CM, Sanyal AJ, et al. Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy. Hepatology (Baltimore, Md). 2005;42:635–640.
  • Kathpalia P, Bhatia A, Robertazzi S, et al. Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites. Intern Med J. 2015;45:1026–1031.
  • EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64:433–485.
  • White J, Carolan-Rees G. PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2012;10:299–308.
  • Narayanan G, Pezeshkmehr A, Venkat S, et al. Safety and efficacy of the PleurX catheter for the treatment of malignant ascites. J Palliat Med. 2014;17:906–912.
  • Courtney A, Nemcek AA Jr, Rosenberg S, et al. Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. J Vasc Interv Radiol. 2008;19: 1723–1731.
  • Carefusion, “Cat. 50-9000B / 50-9900 PleurXTM Peritoneal Catheter Kit. For Peritoneal Placement Only. Sterile. For singe use only. Instructions for use”. Available from: http://www.carefusion.com/documents/guides/directions-for-use/IS_PleurX-Peritoneal-Catheter-Kit_DF_EN.pdf. Accessed February 4, 2018.
  • Solbach P, Honer Zu Siederdissen C, Taubert R, et al. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis. Eur J Gastroenterol Hepatol. 2017;29:539–546.
  • Lacy J. Management of malignant ascites. Surg Gynecol Obstet. 1984;159:16.
  • Enck RE. Malignant ascites [Editorial]. Am J Hosp Palliat Med. 2001;19:2.
  • Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–168.
  • EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:399–420.
  • Reinglas J, Amjadi K, Petrcich B, et al. The palliative management of refractory cirrhotic ascites using the PleurX ((c)) Catheter. Can J Gastroenterol Hepatol. 2016;2016:4680543.
  • Martin DK, Walayat S, Jinma R, et al. Large-volume paracentesis with indwelling peritoneal catheter and albumin infusion: a community hospital study. J Community Hosp Intern Med Perspect. 2016;6:32421.
  • Stirnimann G, Berg T, Spahr L, et al. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. Aliment Pharmacol Ther. 2017;46:981–991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.